Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. [electronic resource]
Producer: 20060526Description: 1032.e1-7 p. digitalISSN:- 1097-6744
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Anticoagulants -- adverse effects
- Drug Therapy, Combination
- Female
- Hemorrhage -- chemically induced
- Heparin -- therapeutic use
- Hirudins -- adverse effects
- Humans
- Male
- Multicenter Studies as Topic
- Myocardial Infarction -- etiology
- Myocardial Revascularization -- statistics & numerical data
- Peptide Fragments -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- adverse effects
- Retrospective Studies
- Risk Assessment
- Sex Factors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.